The latest closing stock price for Black Diamond Therapeutics as of September 18, 2024 is 4.73.
An investor who bought $1,000 worth of Black Diamond Therapeutics stock at the IPO in 2020 would have $-880 today, roughly -1 times their original investment - a -34.58% compound annual growth rate over 5 years.
The all-time high Black Diamond Therapeutics stock closing price was 44.80 on June 22, 2020.
The Black Diamond Therapeutics 52-week high stock price is 7.66, which is 61.9% above the current share price.
The Black Diamond Therapeutics 52-week low stock price is 1.62, which is 65.8% below the current share price.
The average Black Diamond Therapeutics stock price for the last 52 weeks is 4.27.
An investor who bought $1,000 worth of Black Diamond Therapeutics stock at the IPO in 2020 would have $-880 today, roughly -1 times their original investment - a -34.58% compound annual growth rate over 5 years.
The all-time high Black Diamond Therapeutics stock closing price was 44.80 on June 22, 2020.
The Black Diamond Therapeutics 52-week high stock price is 7.66, which is 61.9% above the current share price.
The Black Diamond Therapeutics 52-week low stock price is 1.62, which is 65.8% below the current share price.
The average Black Diamond Therapeutics stock price for the last 52 weeks is 4.27.